ASX - By Stock
|
MSB |
Re:
June 24 - MSB % of portfolio AND + or - %
|
|
Yap2.0
|
88 |
34K |
1 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
88
|
34K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
Yap2.0
|
1.0K |
422K |
5 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
1.0K
|
422K
|
5
|
|
ASX - By Stock
|
PCL |
Re:
General Thoughts
|
|
Yap2.0
|
4.4K |
2.1M |
0 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
4.4K
|
2.1M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
Yap2.0
|
1.3K |
555K |
13 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
1.3K
|
555K
|
13
|
|
ASX - By Stock
|
4DS |
Re:
Ann: imec shipment of Fourth Platform Lot
|
|
Yap2.0
|
276 |
98K |
8 |
21/07/23 |
21/07/23 |
ASX - By Stock
|
276
|
98K
|
8
|
|
ASX - By Stock
|
PCL |
Re:
Ann: Completion of PEL 87 3D Seismic Program
|
|
Yap2.0
|
622 |
312K |
7 |
04/07/23 |
04/07/23 |
ASX - By Stock
|
622
|
312K
|
7
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Trading Halt
|
|
Yap2.0
|
17 |
6.2K |
8 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
17
|
6.2K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Pause in Trading
|
|
Yap2.0
|
74 |
28K |
56 |
08/03/23 |
08/03/23 |
ASX - By Stock
|
74
|
28K
|
56
|
|
ASX - By Stock
|
ZLD |
Re:
General discussion
|
|
Yap2.0
|
395 |
161K |
4 |
20/04/22 |
20/04/22 |
ASX - By Stock
|
395
|
161K
|
4
|
|
ASX - By Stock
|
ZLD |
Re:
Dream big with Zelira
|
|
Yap2.0
|
1.1K |
424K |
0 |
13/01/22 |
13/01/22 |
ASX - By Stock
|
1.1K
|
424K
|
0
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Strategic Transition and Executive Changes
|
|
Yap2.0
|
37 |
14K |
4 |
15/02/21 |
15/02/21 |
ASX - By Stock
|
37
|
14K
|
4
|
|
ASX - By Stock
|
9SP |
Re:
Ann: Suspension from Official Quotation
|
|
Yap2.0
|
137 |
50K |
2 |
30/06/20 |
30/06/20 |
ASX - By Stock
|
137
|
50K
|
2
|
|
ASX - By Stock
|
ZLD |
Re:
Ann: Zelda to merge with US-based Ilera Therapeutics
|
|
Yap2.0
|
314 |
140K |
3 |
10/10/19 |
10/10/19 |
ASX - By Stock
|
314
|
140K
|
3
|
|
ASX - By Stock
|
ZLD |
Re:
Research report
|
|
Yap2.0
|
74 |
35K |
5 |
19/12/18 |
19/12/18 |
ASX - By Stock
|
74
|
35K
|
5
|
|